Acknowledgments
Obinutuzumab was supplied by Roche and Bendamustine was provided by Mundipharma during the trial.
Disclosure statement
Nadine Kutsch Grants: Gilead, AstraZeneca. Payment for lectures including service on speakers bureaus: AstraZeneca, Roche. Honoraria: AstraZeneca, BMS. Travel support from AstraZeneca, Celgene, Gilead, Janssen.
Emily Eva Holmes no conflict of interest
Sandra Robrecht Honoraria: AstraZeneca
Gudrun Schüler no conflict of interest
Ursula Vehling-Kaiser no conflict of interest
Thomas Decker Consultancy and payment for lectures including service on speakers bureaus: Novartis
Sigrun Müller-Hagen no conflict of interest
Karin Heinisch no conflict of interest
Sebastian Böttcher Honoraria: AbbVie, AstraZeneca, Janssen, Roche, Sanof. Consulting or Advisory Role: AbbVie, AstraZeneca, Janssen, Roche, Sanofi. Research Funding: Janssen
Matthias Ritgen Consulting fee or Honorarium: AbbVie, AstraZeneca, Janssen, Roche. Travel support: AbbVie, AstraZeneca, Janssen, Roche. Patents: EuroFlow MRD Diagnostics
Karl-Anton Kreuzer Consultancy: Mundipharma, Roche. Grants Mundipharma, Roche. Payment for lectures including service on speakers bureaus Mundipharma, Roche
Stephan Stilgenbauer fees for consulting, drug/equipment supplied by the entity, travel paid by the entity, writing assistance: AbbVie, AstraZeneca, Celgene, Gilead, Roche, Janssen, Novartis, Morphosys
Anna Maria Fink Grants: AstraZeneca, Celgene. Payment for lectures including service on speakers bureaus: AstraZeneca
Kirsten Fischer Honoraria: AbbVie, Roche. Travel grants: Roche
Barbara Eichhorst Research funding: AbbVie; AstraZeneca, BeiGene; Gilead, Janssen, Roche. Consulting fee or honorarium: AbbVie, AstraZeneca, BeiGene, MSD, Roche. Travel Support: BeiGene. Payment for lectures including service on speakers bureaus: AbbVie, AstraZeneca, BeiGene, MSD, Roche
Michael Hallek Hononraria (speaker's bureau and/or advisory/or advisory board): Roche, Gilead, Janssen, Bristol Myers Squibb, AbbVie, AstraZeneca. Grants: Roche, Gilead, Janssen, Bristol Myers Squibb, AbbVie, AstraZenec
Clemens-Martin Wendtner Consultancy: AbbVie, AstraZeneca, BeiGene, Janssen, Mundipharma, Roche